PortfoliosLab logo
Bio-Techne Corporation (TECH)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US09073M1045

CUSIP

09073M104

IPO Date

Feb 9, 1989

Highlights

Market Cap

$7.89B

EPS (TTM)

$0.83

PE Ratio

60.17

PEG Ratio

1.05

Total Revenue (TTM)

$892.59M

Gross Profit (TTM)

$581.78M

EBITDA (TTM)

$245.55M

Year Range

$46.01 - $85.29

Target Price

$74.61

Short %

4.69%

Short Ratio

3.12

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart


Loading data...

Returns By Period

Bio-Techne Corporation (TECH) returned -30.58% year-to-date (YTD) and -38.07% over the past 12 months. Over the past 10 years, TECH returned 8.07% annually, underperforming the S&P 500 benchmark at 10.46%.


TECH

YTD

-30.58%

1M

1.38%

6M

-34.18%

1Y

-38.07%

5Y*

-6.10%

10Y*

8.07%

^GSPC (Benchmark)

YTD

-3.77%

1M

7.44%

6M

-5.60%

1Y

8.37%

5Y*

14.12%

10Y*

10.46%

*Annualized

Monthly Returns

The table below presents the monthly returns of TECH, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20252.11%-15.94%-5.05%-14.12%-0.81%-30.58%
2024-8.86%4.75%-4.32%-10.20%22.24%-7.18%13.87%-9.22%8.03%-7.73%2.29%-4.42%-6.25%
2023-3.89%-8.72%2.13%7.67%2.49%-0.20%2.17%-5.90%-13.18%-19.74%15.30%22.67%-6.49%
2022-27.24%11.51%3.25%-12.32%-2.53%-6.25%11.15%-13.80%-14.41%4.32%15.31%-2.48%-35.45%
20212.32%11.41%5.60%11.93%-3.12%8.80%7.10%3.58%-2.92%8.06%-9.80%9.60%63.40%
2020-4.35%-9.90%0.39%18.66%17.83%-0.28%4.20%-7.05%-3.03%1.89%20.29%4.69%45.40%
201920.55%11.33%2.40%3.04%-3.04%5.27%0.80%-8.69%2.14%6.39%5.01%0.58%52.67%
20188.29%0.98%6.86%-0.09%-0.18%-1.58%8.58%19.84%6.21%-17.83%-3.58%-10.35%12.60%
2017-1.05%4.81%-4.39%5.34%4.97%4.84%-1.35%7.08%-2.33%8.38%3.11%-3.86%27.40%
2016-8.12%4.20%10.11%-1.42%18.29%2.63%-0.31%-6.00%3.94%-5.03%1.64%-2.40%15.77%
20150.67%5.22%2.83%-4.32%5.86%-2.75%11.08%-13.36%-2.14%-4.61%3.79%-1.33%-1.29%
2014-4.01%-1.89%-3.91%4.62%-1.36%5.44%0.81%2.69%-2.06%-2.67%0.97%0.86%-1.05%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of TECH is 9, meaning it’s performing worse than 91% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of TECH is 99
Overall Rank
The Sharpe Ratio Rank of TECH is 55
Sharpe Ratio Rank
The Sortino Ratio Rank of TECH is 99
Sortino Ratio Rank
The Omega Ratio Rank of TECH is 1111
Omega Ratio Rank
The Calmar Ratio Rank of TECH is 1616
Calmar Ratio Rank
The Martin Ratio Rank of TECH is 22
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Bio-Techne Corporation (TECH) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

Bio-Techne Corporation Sharpe ratios as of May 11, 2025 (values are recalculated daily):

  • 1-Year: -0.97
  • 5-Year: -0.15
  • 10-Year: 0.26
  • All Time: 0.47

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns (including price changes and dividends).

The chart below shows the rolling Sharpe ratio of Bio-Techne Corporation compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time. For deeper analysis or to customize the calculation, use the Sharpe ratio tool.


Loading data...

Dividends

Dividend History

Bio-Techne Corporation provided a 0.48% dividend yield over the last twelve months, with an annual payout of $0.24 per share.


0.20%0.40%0.60%0.80%1.00%1.20%1.40%$0.00$0.10$0.20$0.30$0.40$0.50$0.6020142015201620172018201920202021202220232024
Dividends
Dividend Yield
PeriodTTM20242023202220212020201920182017201620152014
Dividend$0.24$0.32$0.32$0.64$0.32$0.32$0.32$0.32$0.32$0.32$0.32$0.31

Dividend yield

0.48%0.44%0.41%0.77%0.25%0.40%0.58%0.88%0.99%1.24%1.42%1.35%

Monthly Dividends

The table displays the monthly dividend distributions for Bio-Techne Corporation. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025$0.00$0.08$0.00$0.00$0.00$0.08
2024$0.00$0.08$0.00$0.00$0.08$0.00$0.00$0.08$0.00$0.00$0.08$0.00$0.32
2023$0.00$0.08$0.00$0.00$0.08$0.00$0.00$0.08$0.00$0.00$0.08$0.00$0.32
2022$0.00$0.08$0.00$0.00$0.08$0.00$0.00$0.08$0.00$0.00$0.40$0.00$0.64
2021$0.00$0.08$0.00$0.00$0.08$0.00$0.00$0.08$0.00$0.00$0.08$0.00$0.32
2020$0.00$0.08$0.00$0.00$0.08$0.00$0.00$0.08$0.00$0.00$0.08$0.00$0.32
2019$0.00$0.08$0.00$0.00$0.08$0.00$0.00$0.08$0.00$0.00$0.08$0.00$0.32
2018$0.00$0.08$0.00$0.00$0.08$0.00$0.00$0.08$0.00$0.00$0.08$0.00$0.32
2017$0.00$0.08$0.00$0.00$0.08$0.00$0.00$0.08$0.00$0.00$0.08$0.00$0.32
2016$0.00$0.08$0.00$0.00$0.08$0.00$0.00$0.08$0.00$0.00$0.08$0.00$0.32
2015$0.00$0.08$0.00$0.00$0.08$0.00$0.00$0.08$0.00$0.00$0.08$0.00$0.32
2014$0.08$0.00$0.00$0.08$0.00$0.00$0.08$0.00$0.00$0.08$0.00$0.31

Dividend Yield & Payout


Dividend Yield

Bio-Techne Corporation has a dividend yield of 0.48%, which signifies it pays a smaller percentage of its stock price in dividends to its shareholders compared to other companies in the market.

Payout Ratio

Bio-Techne Corporation has a payout ratio of 16.93%, which is below the market average. This means Bio-Techne Corporation returns a smaller proportion of its earnings to shareholders as dividends, suggesting it retains a higher portion for reinvestment, growth, or debt payment.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading data...

Worst Drawdowns

The table below displays the maximum drawdowns of the Bio-Techne Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Bio-Techne Corporation was 74.39%, occurring on Apr 7, 2003. Recovery took 1283 trading sessions.

The current Bio-Techne Corporation drawdown is 62.26%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-74.39%Jul 5, 2000691Apr 7, 20031283May 12, 20081974
-64.1%Sep 27, 2021895Apr 21, 2025
-52.71%Feb 4, 1993378Aug 4, 1994264Aug 21, 1995642
-43.8%Aug 11, 2008145Mar 9, 2009543May 3, 2011688
-38.75%Mar 23, 1998113Aug 31, 199877Dec 18, 1998190

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading data...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Bio-Techne Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Earnings Per Share

The chart presents the Earnings Per Share (EPS) performance of Bio-Techne Corporation, comparing actual results with analytics estimates. The company has exceeded analyst expectations for EPS in the past quarter, achieving a 10.4% positive surprise.


0.200.300.400.500.6020212022202320242025
0.56
0.51
Actual
Estimate

Valuation

The Valuation section provides an overview of how Bio-Techne Corporation is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio

The chart displays the Price-to-Earnings (P/E) ratio for TECH, comparing it with other companies in the Biotechnology industry. Currently, TECH has a P/E ratio of 60.2. This P/E ratio is significantly higher than those of industry peers. This could indicate that the stock is overvalued or that investors expect strong future growth.

PEG Ratio

The chart shows the Price/Earnings to Growth (PEG) ratio for TECH compared to other companies in the Biotechnology industry. TECH currently has a PEG ratio of 1.0. This PEG ratio is close to the industry average, suggesting the stock’s valuation is balanced against its growth outlook.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for TECH relative to other companies in the Biotechnology industry. Currently, TECH has a P/S ratio of 6.5. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for TECH in comparison with other companies in the Biotechnology industry. Currently, TECH has a P/B value of 3.9. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items